Cancer Genomics 2017 will update you on the latest exciting developments: cancers as communities of clones and communities of cells, liquid biopsies, genomics and cancer immunology, mutational processes, and genomic and immune system landscapes of human cancers.
Featuring an exceptional international faculty, extensive networking opportunities and a maximum of 200 participants, this conference will provide an intimate setting for top quality scientific interaction.
Who should attend? Cancer Genomics 2017 will be relevant to participants from across a number of fields including cancer medicine, cancer biology, translational research, bioinformatics, epigenomics, cancer immunology and molecular pathology. Importantly, early career researchers will have the opportunity to present their work to the international community.
Featuring an exceptional international faculty, extensive networking opportunities and a maximum of 200 participants, this conference will provide an intimate setting for top quality scientific interaction.
Who should attend? Cancer Genomics 2017 will be relevant to participants from across a number of fields including cancer medicine, cancer biology, translational research, bioinformatics, epigenomics, cancer immunology and molecular pathology. Importantly, early career researchers will have the opportunity to present their work to the international community.
